Understand the source comparison
GHRP-2 Acetate GHSR Ghrelin Mechanism: Peptide Type Comparison
GHRP-2 Acetate GHSR-1a (hypothalamic neurons) 0.7 nM 20–30 minutes Moderate. Partial override during first 60 minutes of pulse Optimal balance of receptor selectivity and GH pulse amplitude; acetate salt provides superior stability without requiring specialize
No winner is assigned.
This page preserves a source comparison for education. It does not add a rating, recommendation or clinical judgment.
- GHRP-2 Acetate
- GHSR-1a (hypothalamic neurons)
- 0.7 nM
- 20–30 minutes
- Moderate. Partial override during first 60 minutes of pulse
- Optimal balance of receptor selectivity and GH pulse amplitude; acetate salt provides superior stability without requiring specialized storage beyond standard refrigeration
- Endogenous Acyl-Ghrelin
- GHSR-1a (hypothalamic + peripheral)
- 2.1 nM
- 15–25 minutes
- Minimal. Easily suppressed by tonic somatostatin
- Physiological baseline; broader tissue distribution reduces central GH-releasing potency per mole
- GHRP-6
- GHSR-1a + appetite-regulating subtypes
- 1.2 nM
- 25–35 minutes
- Low. Minimal somatostatin resistance
- Higher off-target binding increases hunger signaling; less suitable for GH-focused research
- Ipamorelin
- GHSR-1a (high selectivity)
- 1.5 nM
- 30–40 minutes
- Very Low. Works synergistically with endogenous rhythms
- Produces smoother, lower-amplitude pulses; ideal for models requiring minimal disruption to endogenous GH patterns
- Hexarelin
- GHSR-1a + CD36 scavenger receptor
- 0.9 nM
- High. Strong somatostatin override
- Significant cardiac and metabolic off-target effects via CD36 binding; limits utility in isolated GH pathway studies
- The ghrp-2 acetate ghsr ghrelin mechanism occupies a middle ground between ipamorelin's gentler action and hexarelin's aggressive somatostatin override. For research models investigating pulsatile GH dynamics without confounding cardiovascular effects, GHRP-2 acetate offers the cleanest pharmacological profile. The acetate salt adds negligible molecular weight (59 Da vs peptide backbone ~817 Da) but dramatically improves handling characteristics compared to free-base or trifluoroacetate forms.